Unreported symptomatic exacerbation and progressive pulmonary fibrosis in patients with interstitial lung disease: prospective observational study using a disease management system (YaDoc)

Unreported symptomatic exacerbation and progressive pulmonary fibrosis in patients with interstitial lung disease: prospective observational study using a disease management system (YaDoc) - uSE and PPF in patients with ILD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049420

Enrollment

Registered

2022-11-04

Start date

2022-11-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ILD Patients using or new to YaDoc

Exclusion criteria

Exclusion criteria: Cases in which the patient refuses to participate in the study with regard to the content of the study Patients who have difficulty understanding the action plan Patients deemed inappropriate by the attending physician

Design outcomes

Primary

Measure	Time frame
Evaluate the association PPF with uSE	—

Secondary

Measure	Time frame
Prevalence of uSE, action plan adherence, reasons and frequency of unscheduled visits and comparison to uSE, analysis of early predictors of acute exacerbations of ILD, trends in patient-reported outcomes, medication adherence rates, YaDoc adherence, YaDoc safety	—

Countries

Japan

Contacts

Public ContactTomoki Kimura

Tosei General Hospital Department of Respiratory Medicine and Allergy

tomoki_kimura@tosei.or.jp0561-82-5101

Outcome results